Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 472-110-0 | CAS number: 71868-15-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 Sep - 14 Oct 2004 (experimental period)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratoires, L'Arbresle Cedex, France.
- Females nulliparous and non-pregnant: yes .
- Age at study initiation: 8-12 weeks at the time of administration.
- Weight at study initiation: Within ± 20% of the mean weight of any previously dosed animals.
- Fasting period before study: yes, deprived of food since the previous day.
- Housing: Daily observations were performed at the time of delivery of the animals and during the period of acclimatization. Animals were housed in cages of standard dimensions with sawdust bedding (or equivalent). Cages were cleaned at least once per week. The animals were placed in an air-conditioned (19-23°C) animal house kept at relative humidity between 45% and 65% in which non-recycled filtered air was changed approximately 10 times per hour. The artificial day/night cycle involved 12 hours light and 12 hours darkness with light on at 7.30 a.m.
- Diet (e.g. ad libitum): RM1 (E)-SQC SDS/DIETEX feed (quality controlled/radiation sterilised) was available ad libitum (except during the fasting experimental period). The criteria for acceptable levels of contaminants in the feed supply were within the limits of the analytical specifications established by the diet manufacturer.
- Water (e.g. ad libitum): Drinking water was available ad libitum in polycarbonate feeder bottles with a stainless steel nipple. A specimen of water is obtained every 6 months and sent to a laboratory for analysis. The criteria for acceptable levels of contaminants in the water supply were within the limits of the analytical specifications.
- Acclimation period: Minimum of five days before treatment in the laboratory animal house where the experiment took place. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- - Vehicle: sterile water
- dose volume applied: 10mL/kg - Doses:
- 2000 mg/kg bw (limit test; at request of the sponsor)
- No. of animals per sex per dose:
- 6 females
- Control animals:
- no
- Preliminary study:
- -
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no 95% CL stated
- Mortality:
- There were no deaths.
- Clinical signs:
- other: No clinical signs were observed from D1 to D14 during the course of the first step of the study. On D1 (about 3 hours 30 minutes post-dosing), all females presented a piloerection during the second step of the study. No clinical signs were observed from D
- Gross pathology:
- No organ or tissue gross findings were seen at necropsy
- Other findings:
- none
- Interpretation of results:
- other: EU-GHS criteria not met
- Conclusions:
- LD50 > 2000 mg/kg bw
- Executive summary:
A study was conducted to determine the acute oral toxicity of the test substance in female SD rats according to OECD Guideline 423, in compliance with GLP. At the first step, a group of three females was treated with the starting dose of 2000 mg/kg bw, followed by an additional group of three animals at the same dose level. The test substance was administered orally to animals deprived of food since the previous day, in a volume of 10 mL/kg as a white homogeneous suspension in sterile water. The rats were monitored daily for 14 days after administration of the test substance. Bodyweight was recorded on Days 1, 7, 14 and 15. No mortality occurred during the study. No clinical signs were observed from Day 1 to 14 in the first step of the study. On Day 1 (about 3.5 h post-dosing), all females presented piloerection during the second step of the study. No further clinical signs were recorded. Mean bodyweight gain in treated animals was within the expected normal range. No organ or tissue gross findings were seen at necropsy. Under the study conditions, the acute oral LD50 of the test substance in rats was greater than 2000 mg/kg bw (Baudet, 2004).
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral
A study was conducted to determine the acute oral toxicity of the test substance in female SD rats according to OECD Guideline 423, in compliance with GLP. At the first step, a group of three females was treated with the starting dose of 2000 mg/kg bw, followed by an additional group of three animals at the same dose level. The test substance was administered orally to animals deprived of food since the previous day, in a volume of 10 mL/kg as a white homogeneous suspension in sterile water. The rats were monitored daily for 14 days after administration of the test substance. Bodyweight was recorded on Days 1, 7, 14 and 15. No mortality occurred during the study. No clinical signs were observed from Day 1 to 14 in the first step of the study. On Day 1 (about 3.5 h post-dosing), all females presented piloerection during the second step of the study. No further clinical signs were recorded. Mean bodyweight gain in treated animals was within the expected normal range. No organ or tissue gross findings were seen at necropsy. Under the study conditions, the acute oral LD50 of the test substance in rats was greater than 2000 mg/kg bw (Baudet, 2004).
Dermal
The study does not need to be conducted because the substance does not meet the criteria for classification for acute toxicity or STOT SE by the oral route and no systemic effects have been observed in in vivo skin irritation or skin sensitization studies using dermal exposure.
Inhalation
According to REACH Annex VIII column 2, 8.5.2., testing by the inhalation route is appropriate if exposure of humans via inhalation is likely, considering the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles, or droplets of an inhalable size. This is not the case since the estimated vapour pressure of the substance is 1.44E-9 Pa at 25°C and, as it is a solid, no droplets of inhalable size will be formed. Therefore, no acute oral inhalation testing was conducted.
Justification for classification or non-classification
Based on the results of an acute oral toxicity test (OECD Guideline 423), the test substance does not meet the CLP classification criteria for this endpoint, as set out in Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)